INTERNATIONAL PATENT: CELLENKOS, INC. FILES APPLICATION FOR "USES OF REGULATORY T CELLS FOR TREATING MYELOFIBROSIS"

GENEVA, May 12 -- CELLENKOS, INC. (5416 Chaucer DriveHouston, Texas 77005) filed a patent application (PCT/IB2024/060685) for "USES OF REGULATORY T CELLS FOR TREATING MYELOFIBROSIS" on Oct 30, 2024. With publication no. WO/2025/094066, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PARMAR, Simrit (5122 Morningside DriveApt. 1025Houston, Texas 77005)

Abstract: Provided herein are medical uses of CXCR4-enriched T regulatory cells in combination with ruxolitinib for treating myelofibrosis or ameliorating a symptom of mye...